Sr. Investment Analyst
Mike is a Senior Investment Analyst for Merck GHI Fund and is responsible for supporting all areas of digital health. Prior to joining Merck in 2021, Mike was a Senior Manager in the Life Sciences Strategy Practice at Accenture. His experience includes venture capital, M&A due-diligence, business case development, real-world evidence, and growth strategy. Mike holds an MBA from Yale School of Management and a BA from Haverford College.